Replies to post #93829 on Biotech Values

[genisi]

It won't be long before Teva will make an acquisition in South America and Brazil looks like the top target. Sanofi is ahead of Teva there as it already bought the largest generics company - Medley. I think the Chinese market is probably still too fragmented to be a current top priority target for Teva, and they are waiting for regulatory changes to make a move.